Atlas Trials

Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic Rosacea

Clinical trial NCT04153188 · COMPLETED

Trial details

NCT number
NCT04153188
Sponsor
Candela Corporation
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Erythematotelangiectatic Rosacea
Start date
2019-01-15
Primary completion
2020-11-13
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.